Blood Purification

Papers
(The H4-Index of Blood Purification is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
ISBP 2025 Kidney Health Congress Abstract40
Protocol for a Randomized, Open-Label, Multicenter, Parallel-Controlled Study Evaluating Modified Double Filtration Plasmapheresis for the Treatment of Septic Shock31
Vancomycin and Gentamicin Removal with the HA380 Cartridge during Experimental Hemoadsorption23
The Brophy Kit™: An in-vivo experimental model of ultrafiltration for extremely low birthweight neonates23
Determinants of Urine Output Using Advanced Hemodynamic Monitoring in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy22
Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®21
Low Antithrombin III Activity, Nafamostat Monotherapy without Heparin, and Small Filter Size Are Associated with a Shorter Circuit Lifespan in Pediatric Continuous Kidney Replacement Therapy: A Single21
e-Prescribing, Charting, and Documentation for Continuous Renal Replacement Therapy: A Green Intensive Care Unit and Nephrology Initiative19
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with Hyperbilirubinemia19
Effectiveness of Multidisciplinary Post-Acute Kidney Injury Clinic on Awareness and Knowledge in Acute Kidney Injury Survivors19
Acknowledgement to Reviewers18
Optimizing Safety and Efficacy in Pediatric Continuous Renal Replacement: The Promise of Diluted Regional Citrate Anticoagulation17
Randomized Trial of Pharmacist Integration in Haemodialysis Teams: Effects on Phosphorus Control and Patient Outcomes15
Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study15
Bilirubin Removal with Therapeutic Plasma Exchange or Molecular Adsorbent Recirculating System as Treatment for Cholemic Nephropathy in Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Ca15
0.18381094932556